Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam effects on TMS-EMG and TMS-EEG cortical excitability measures in treatment-controlled epilepsy
NL-OMON49353Recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levetiracetam in epilepsy (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Resting motor threshold, Motor evoked potential peak-to-peak amplitude and 8 more. Started Jul 2020; status: recruiting.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON49353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49353.